Topics:
Gastrointestinal Cancers • Medical Oncology
Would you consider a distal esophageal adenocarcinoma as a GEJ cancer to be able to use immune check point inhibitor therapy?
Since immune check point inhibitors have been approved for GEJ and gastric cancer, would a distal esophogeal adenocarcinoma be considered GEJ or does part of the cancer have to extend into the stomach?
Answer from: Medical Oncologist at Academic Institution
Yes
Sign in or Register to read more